Market Closed -
Nyse
01:30:02 27/04/2024 am IST
|
5-day change
|
1st Jan Change
|
27.32
USD
|
+1.07%
|
|
+5.44%
|
-13.38%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,958
|
4,078
|
5,469
|
4,621
|
4,682
|
4,067
|
-
|
-
|
Enterprise Value (EV)
1 |
6,175
|
6,999
|
7,767
|
7,134
|
7,517
|
7,143
|
7,044
|
7,257
|
P/E ratio
|
-56.5
x
|
18.8
x
|
9.32
x
|
8.39
x
|
-19.7
x
|
16.7
x
|
7.78
x
|
5.17
x
|
Yield
|
5.53%
|
4.03%
|
2.98%
|
3.27%
|
-
|
3.75%
|
3.85%
|
4.26%
|
Capitalization / Revenue
|
0.54
x
|
0.82
x
|
0.86
x
|
0.68
x
|
0.78
x
|
0.69
x
|
0.63
x
|
0.62
x
|
EV / Revenue
|
1.12
x
|
1.41
x
|
1.22
x
|
1.05
x
|
1.25
x
|
1.22
x
|
1.09
x
|
1.1
x
|
EV / EBITDA
|
6.05
x
|
7.96
x
|
5.92
x
|
5.24
x
|
7.41
x
|
7.69
x
|
5.85
x
|
5.28
x
|
EV / FCF
|
36.5
x
|
13
x
|
14.3
x
|
16
x
|
40.4
x
|
-33.2
x
|
26.1
x
|
13.8
x
|
FCF Yield
|
2.74%
|
7.72%
|
6.99%
|
6.27%
|
2.47%
|
-3.01%
|
3.83%
|
7.27%
|
Price to Book
|
4.29
x
|
5.03
x
|
5
x
|
4.11
x
|
6.36
x
|
37.4
x
|
16.7
x
|
7.67
x
|
Nbr of stocks (in thousands)
|
1,63,501
|
1,64,496
|
1,62,961
|
1,50,918
|
1,48,438
|
1,48,881
|
-
|
-
|
Reference price
2 |
18.09
|
24.79
|
33.56
|
30.62
|
31.54
|
27.32
|
27.32
|
27.32
|
Announcement Date
|
13/02/20
|
11/02/21
|
10/02/22
|
09/02/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,526
|
4,969
|
6,345
|
6,794
|
6,027
|
5,854
|
6,435
|
6,570
|
EBITDA
1 |
1,020
|
879
|
1,313
|
1,361
|
1,014
|
928.5
|
1,203
|
1,376
|
EBIT
1 |
709
|
559
|
996
|
1,070
|
707
|
588.1
|
889.7
|
1,030
|
Operating Margin
|
12.83%
|
11.25%
|
15.7%
|
15.75%
|
11.73%
|
10.05%
|
13.83%
|
15.68%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
741
|
-
|
305
|
657
|
986
|
Net income
1 |
-52
|
-
|
608
|
578
|
-238
|
247
|
532
|
799
|
Net margin
|
-0.94%
|
-
|
9.58%
|
8.51%
|
-3.95%
|
4.22%
|
8.27%
|
12.16%
|
EPS
2 |
-0.3200
|
1.320
|
3.600
|
3.650
|
-1.600
|
1.640
|
3.510
|
5.280
|
Free Cash Flow
1 |
169
|
540
|
543
|
447
|
186
|
-215.3
|
270
|
527.3
|
FCF margin
|
3.06%
|
10.87%
|
8.56%
|
6.58%
|
3.09%
|
-3.68%
|
4.2%
|
8.03%
|
FCF Conversion (EBITDA)
|
16.57%
|
61.43%
|
41.36%
|
32.84%
|
18.34%
|
-
|
22.44%
|
38.33%
|
FCF Conversion (Net income)
|
-
|
-
|
89.31%
|
77.34%
|
-
|
-
|
50.75%
|
66%
|
Dividend per Share
2 |
1.000
|
1.000
|
1.000
|
1.000
|
-
|
1.025
|
1.052
|
1.165
|
Announcement Date
|
13/02/20
|
11/02/21
|
10/02/22
|
09/02/23
|
27/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
1,680
|
1,575
|
1,764
|
1,915
|
1,777
|
1,338
|
1,536
|
1,643
|
1,487
|
1,361
|
1,410
|
1,593
|
1,577
|
1,430
|
1,522
|
EBITDA
1 |
372
|
307
|
403
|
475
|
363
|
120
|
304
|
324
|
247
|
176
|
160
|
264.8
|
261
|
212.6
|
282.7
|
EBIT
1 |
294
|
231
|
329
|
403
|
291
|
46
|
225
|
246
|
171
|
102
|
84.06
|
216.5
|
187
|
143.5
|
233.3
|
Operating Margin
|
17.5%
|
14.67%
|
18.65%
|
21.04%
|
16.38%
|
3.44%
|
14.65%
|
14.97%
|
11.5%
|
7.49%
|
5.96%
|
13.59%
|
11.86%
|
10.03%
|
15.33%
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
231
|
299
|
-
|
173
|
-433
|
-
|
-71
|
16
|
117
|
115
|
57
|
113
|
Net income
1 |
214
|
233
|
234
|
201
|
240
|
-97
|
145
|
-376
|
-
|
-18
|
13
|
95
|
93
|
46
|
91
|
Net margin
|
12.74%
|
14.79%
|
13.27%
|
10.5%
|
13.51%
|
-7.25%
|
9.44%
|
-22.88%
|
-
|
-1.32%
|
0.92%
|
5.96%
|
5.9%
|
3.22%
|
5.98%
|
EPS
2 |
1.270
|
1.400
|
1.430
|
1.260
|
1.520
|
-0.6500
|
0.9600
|
-2.520
|
-
|
-0.1200
|
0.0900
|
0.6200
|
0.6100
|
0.3000
|
0.5900
|
Dividend per Share
2 |
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
-
|
Announcement Date
|
04/11/21
|
10/02/22
|
02/05/22
|
28/07/22
|
25/10/22
|
09/02/23
|
27/04/23
|
28/07/23
|
26/10/23
|
27/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
3,217
|
2,921
|
2,298
|
2,513
|
2,835
|
3,075
|
2,976
|
3,190
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.154
x
|
3.323
x
|
1.75
x
|
1.846
x
|
2.796
x
|
3.312
x
|
2.473
x
|
2.319
x
|
Free Cash Flow
1 |
169
|
540
|
543
|
447
|
186
|
-215
|
270
|
527
|
ROE (net income / shareholders' equity)
|
49.2%
|
43.8%
|
64.2%
|
67.5%
|
46.1%
|
46.9%
|
143%
|
96.5%
|
ROA (Net income/ Total Assets)
|
5.73%
|
4.59%
|
8.31%
|
9.72%
|
5.35%
|
3.85%
|
5.57%
|
6.75%
|
Assets
1 |
-907.2
|
-
|
7,316
|
5,948
|
-4,449
|
6,412
|
9,548
|
11,844
|
Book Value Per Share
2 |
4.210
|
4.930
|
6.710
|
7.450
|
4.960
|
0.7300
|
1.640
|
3.560
|
Cash Flow per Share
2 |
3.940
|
-
|
4.860
|
4.760
|
3.690
|
0.5000
|
2.060
|
4.800
|
Capex
1 |
481
|
267
|
277
|
307
|
370
|
438
|
447
|
403
|
Capex / Sales
|
8.7%
|
5.37%
|
4.37%
|
4.52%
|
6.14%
|
7.49%
|
6.94%
|
6.14%
|
Announcement Date
|
13/02/20
|
11/02/21
|
10/02/22
|
09/02/23
|
27/03/24
|
-
|
-
|
-
|
Last Close Price
27.32
USD Average target price
31.27
USD Spread / Average Target +14.46% Consensus |
1st Jan change
|
Capi.
|
---|
| -13.38% | 4.07B | | -0.19% | 74.89B | | +0.09% | 46.52B | | -4.19% | 30.82B | | +9.85% | 18.19B | | -10.05% | 11.54B | | -8.09% | 9.73B | | +2.79% | 9.4B | | +6.35% | 9.37B | | +3.85% | 8.11B |
Diversified Chemicals
|